Alliance Pharma PLC (STU:DVL)
€ 0.52 0.005 (0.97%) Market Cap: 296.49 Mil Enterprise Value: 400.78 Mil PE Ratio: 0 PB Ratio: 1.12 GF Score: 75/100

Half Year 2023 Alliance Pharma PLC Earnings Call Transcript

Sep 26, 2023 / 08:30AM GMT
Release Date Price: €0.525 (+1.94%)
Peter Butterfield

Okay. Good morning, everybody. And a very warm welcome to our 2023 interim results presentation. My name is Pete Butterfield. I'm the CEO of Alliance, and I'm pleased to be joined by Andrew Franklin, our CFO, as always; and Jeyan Heper as well. And as you may remember, Jeyan joined Alliance in February as Chief Operating Officer.

He has over 25 years' experience gained in international consumer health care businesses. So, today, you'll hear a lot more about the growth plans and the key drivers behind our main brands from him later in the presentation.

So today, I'll cover the business performance for the first 6 months of the year. I'll then hand to Jeyan to talk you through our key brands and their performance. Finally, Andrew will go through the financial detail of the first 6 months, concluding with a summary and outlook for this year. And after that, we'll be happy to take any questions, both in the room and I think online as well.

Okay. You should be quite familiar with our headline results following the publication of our trading update in July. So I won't

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot